RANI (STOCKS)
Rani Therapeutics Holdings, Inc. Class A Common Stock
$0.770100
+0.030100 (+4.07%)
Prev close: $0.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Talat Imran
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $95.48M
- Employees
- 106
- P/E (TTM)
- -1.32
- P/B (TTM)
- 2.19
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.07 | $-0.07 | -0.0020 | -2.94% |
|
Sep 2025 (Q3)
|
$-0.12 | $-0.13 | +0.0058 | +4.61% |
|
Jun 2025 (Q2)
|
$-0.18 | $-0.20 | +0.0189 | +9.50% |
|
Mar 2025 (Q1)
|
$-0.22 | $-0.21 | -0.0126 | -6.08% |
Financial Statements
| Revenues | $1.63M |
| Benefits Costs and Expenses | $42.58M |
| Costs And Expenses | $42.58M |
| Operating Expenses | $39.94M |
| Depreciation and Amortization | $900.00K |
| Research and Development | $20.21M |
| Other Operating Expenses | $18.84M |
| Operating Income/Loss | -$38.31M |
| Income/Loss From Continuing Operations After Tax | -$40.95M |
| Income/Loss From Continuing Operations Before Tax | -$40.95M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $2.89M |
| Net Income/Loss | -$40.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$11.28M |
| Net Income/Loss Attributable To Parent | -$29.67M |
| Net Income/Loss Available To Common Stockholders, Basic | -$29.67M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.45 |
| Diluted Earnings Per Share | -$0.45 |
| Basic Average Shares | 66,138 |
| Diluted Average Shares | 66,138 |
| Assets | $58.62M |
| Current Assets | $53.32M |
| Prepaid Expenses | $1.57M |
| Other Current Assets | $51.75M |
| Noncurrent Assets | $5.30M |
| Fixed Assets | $736.00K |
| Other Non-current Assets | $4.56M |
| Liabilities | $17.11M |
| Current Liabilities | $12.67M |
| Accounts Payable | $309.00K |
| Other Current Liabilities | $12.36M |
| Noncurrent Liabilities | $4.44M |
| Equity | $41.51M |
| Equity Attributable To Noncontrolling Interest | $8.50M |
| Equity Attributable To Parent | $33.01M |
| Liabilities And Equity | $58.62M |
| Net Cash Flow From Operating Activities | -$18.71M |
| Net Cash Flow From Operating Activities, Continuing | -$18.71M |
| Net Cash Flow From Investing Activities | -$7.03M |
| Net Cash Flow From Investing Activities, Continuing | -$7.03M |
| Net Cash Flow From Financing Activities | $40.30M |
| Net Cash Flow From Financing Activities, Continuing | $40.30M |
| Net Cash Flow | $14.56M |
| Net Cash Flow, Continuing | $14.56M |
| Comprehensive Income/Loss | -$40.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$11.28M |
| Comprehensive Income/Loss Attributable To Parent | -$29.68M |
| Other Comprehensive Income/Loss | -$6.00K |